Header Logo

Calvin Ho, MD

TitleClinical Assistant Professor
InstitutionCharles R. Drew University of Medicine and Science
DepartmentPhysical Med & Rehab
Address1731 E. 120th Street
Los Angeles CA 90059
PhoneNot Available
FaxNot Available
vCardDownload vCard

    Bibliographic
    selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Merkel PA, Nair PK, Khalidi N, Terrier B, Hellmich B, Bourdin A, Jayne DRW, Jackson DJ, Roufosse F, Pagnoux C, Specks U, B?rjesson Sj? L, Ho CN, Jison M, McCrae C, Necander S, Rodr?guez-Su?rez E, Shavit A, Walton C, Wechsler ME, MANDARA Study Group. Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitis. Ann Rheum Dis. 2025 Nov; 84(11):1888-1899. PMID: 40781045.
      Citations:    Fields:    
    2. Ho CN, Bahadori L, Yale M, Bishop N, Roberts C, Meyers O, Bailey J, Korman NJ. Patient Experiences of Bullous Pemphigoid: Symptoms and Health-Related Quality of Life Impacts. Dermatol Ther (Heidelb). 2025 Jul; 15(7):1813-1831. PMID: 40366568; PMCID: PMC12126422.
      Citations:    
    3. Altrichter S, Gim?nez-Arnau AM, Bernstein JA, Metz M, Bergquist M, Brooks L, Ho CN, Jain P, Lukka PB, Rodriguez-Su?rez E, Walton C, Bahadori L. Benralizumab for the treatment of chronic spontaneous urticaria: a plain language summary of the ARROYO study. Immunotherapy. 2025 Mar; 17(4):229-238. PMID: 40159728; PMCID: PMC12013436.
      Citations:    Fields:    
    4. Ho CN, Fj?llbrant H, Dellon ES, Santander C, Rothenberg ME, Bailey J, McFadden S, Ritchie J. Patient experience with eosinophilic esophagitis symptoms and impacts on daily life based on in-trial qualitative interviews. J Patient Rep Outcomes. 2025 Jan 08; 9(1):3. PMID: 39777591; PMCID: PMC11711566.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    5. Ho CN, K?ndig A, Bahadori L, Roat K, Bruce R, Goswami CP, Kelly K, Moll T. Assessing usability of electronic patient-reported outcome measures in older people with and without a rare dermatologic disorder. J Patient Rep Outcomes. 2024 Dec 18; 8(1):145. PMID: 39692800; PMCID: PMC11655768.
      Citations:    Fields:    Translation:Humans
    6. Altrichter S, Gim?nez-Arnau AM, Bernstein JA, Metz M, Bahadori L, Bergquist M, Brooks L, Ho CN, Jain P, Lukka PB, Rodriguez-Su?rez E, Walton C, Datto CJ, ARROYO Study Investigators . Benralizumab does not elicit therapeutic effect in patients?with chronic spontaneous urticaria: results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trial. Br J Dermatol. 2024 Jul 16; 191(2):187-199. PMID: 38367194.
      Citations: 9     Fields:    Translation:HumansCellsCTClinical Trials
    7. Rothenberg ME, Dellon ES, Collins MH, Bredenoord AJ, Hirano I, Peterson KA, Brooks L, Caldwell JM, Fj?llbrant H, Grindebacke H, Ho CN, Keith M, McCrae C, Sinibaldi D, White WI, Datto CJ, MESSINA Trial Investigators. Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis. N Engl J Med. 2024 Jun 27; 390(24):2252-2263. PMID: 38924732.
      Citations: 25     Fields:    Translation:HumansCellsCTClinical Trials
    8. Guttman-Yassky E, Bahadori L, Brooks L, Clark KL, Grindebacke H, Ho CN, Katial R, Pham TH, Walton C, Datto CJ, HILLIER study investigators. Treating moderate-to-severe atopic dermatitis with benralizumab: results from the HILLIER study, a plain language summary. Immunotherapy. 2024; 16(10):641-648. PMID: 38695680; PMCID: PMC11407287.
      Citations: 1     Fields:    Translation:Humans
    9. Ho CN, O'Quinn S, Bailey J, Meyers O, Slagle AF, Dellon ES, Datto C. Development and content validation of a symptom assessment for eosinophilic gastritis and eosinophilic gastroenteritis in adults and adolescents. Orphanet J Rare Dis. 2021 11 24; 16(1):495. PMID: 34819137; PMCID: PMC8611867.
      Citations: 3     Fields:    Translation:Humans
    Ho's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (44)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _